PATENT CLAIM ANALYSIS

Application Number: 15951277
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "025000"]

Abstract:
The invention relates to phenoxy derivatives with glycosidically bound sugar moieties, pharmaceutical compositions containing such compounds, uses of such compounds and compositions, and methods of making such compounds and pharmaceutical compositions.

Claim (Index 1):
A compound of the general Formula I wherein R1 and R10, identical or different, is selected from \u2014H, \u2014OH, C1-C6 alkyl, linear or branched, saturated or not saturated, unsubstituted or substituted with \u2014COOR4, \u2014CONR5R6, and/or \u2014NR5R6, wherein R4, R5 and R6, identical or different, is selected from \u2014H, \u2014C1-C6 alkyl, linear or branched, saturated or not saturated, or \u2014(CH2)n-COOR7, with n=1-5, and R7 is \u2014H or \u2014C1-C6 alkyl, linear or branched, saturated or not saturated, wherein R2 and R3 are moieties separable microbiotically or by the human organism, identical or different, which when separated are physiologically tolerable, and wherein after separation of the moieties R2 and R3 a catechol derivative with R1 in position 4 is formed, and wherein R1 alternatively may be arranged vicinally to the group \u2014O\u2014R2, or physiologically tolerable salts of such compounds, not however a compound from the group consisting of 5-allyl-catechol-bis(\u03b2-D-glucopyranoside), 3-O-\u03b1-D-glucopyranosyl-dopamine, 4-O-\u03b1-D-glucopyranosyl-dopamine, 3-O-\u03b1-D-glucopyranosyl-DOPA, 4-O-\u03b1-D-glucopyranosyl-DOPA, 3-O-\u03b1-D-manopyranosyl-dopamine, 4-O-\u03b1-D-manopyranosyl-dopamine, 3-O-\u03b1-D-galactopyranosyl-dopamine, 4-O-\u03b1-D-galactopyranosyl-dopamine, 3-O-\u03b1-D-2-desoxyglucopyranosyl-dopamine, 4-0-\u03b1-D-2-desoxyglucopyranosyl-dopamine, 3-O-\u03b1-D-O-methylglucopyranosyl-dopamine, 4-O-\u03b1-D-O-methylglucopyranosyl-dopamine, dihydro-caffeic acid-diglucoside, 3,4-dihydroxy-allylbenzene-3-O-\u03b1-L-rhamnopyranosyl (1\u21926)-\u03b2-D-glucopyranoside, and 3,4-dihydroxy-allylbenzene-3-O-\u03b1-L-rhamnopyranosyl(1\u21922)-\u03b2-D-glucopyranoside, for the prophylaxis or treatment of a disease of man or animal from the group consisting of peripheral and autonomic neuropathies, central nervous degenerative diseases, high blood pressure, arteriosclerosis, venous insufficiency, diabetes mellitus, osteoporosis, cataract, and photoaging of the skin, or for the use of such a compound for the prophylaxis or treatment of such a disease.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.52174
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13274814', '12512696', '12819801', '11166881', '10000720']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7567528756165399
- 35 USC 102 Novelty (BERT): 0.5181126683624222
- Combined Prediction Score: 0.7328888548911282
- Mean Citation Score: 216.440334
- Max Citation Score: 234.24812000000003
- Similarity Product: 133.94438595084668

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test